Discussion on the Pathogenesis of Tumor Based on "Yang Transforming into Qi with Yin Constituting Form" and Fu-Yang Doctrine
-
摘要: 中医对肿瘤病机的研究一直是中医基础研究的热点，该研究基于“阳化气，阴成形”及伏阳学说，结合了现代医学研究成果，系统阐述了肿瘤发病的病机。认为肿瘤的发生发展可能与内外因作用下形成的阳虚阴盛体质有关。该体质状态下机体容易产生与现代医学中的增生、结节、息肉等概念类似的痰、湿、瘀、毒等病理产物。同时阳虚化气不足，气虚气滞，加上阴邪郁闭，导致郁热，形成了伏阳环境。在肿瘤恶化与转移的过程中，痰、湿、瘀、毒等阴邪与伏阳相互作用，最终导致肿瘤的迁移。基于此，提出了清郁热与散寒结相结合的肿瘤治法。Abstract: The research on the pathogenesis of tumor has been a hot topic in the basic field of traditional Chinese medicine. Thus, the study combined with modern medical research results based on "yang transforming into qi with yin constituting form" and fu-yang doctrine to systematically explain the mechanism of tumor formation. It is believed that the formation and development of tumor may be related to the deficiency of yang with exuberance of yin in the body due to internal and external factors. That physique is prone to produce phlegm, dampness, stasis, toxin and other pathological products, which are similar to the concepts of hyperplasia, nodules and polyps in modern medicine. At the same time, the insufficient yang transforming into qi, and the deficiency and stagnation of qi, coupled with the stagnation of yin pathogens, lead to the constraint-heat resulting in fu-yang. In the process of tumor deterioration and metastasis, yin pathogens such as phlegm, dampness, stasis, and toxin interact with fu-yang and eventually lead to the migration of tumors. Based on this, we propose a treatment on tumor that combines clearing the constraint-heat with dispersing the cold accumulations.
-
[1] 付西, 肖冲, 任益锋, 等. 整体观视域下的中医肿瘤发生学[J]. 北京中医药大学学报, 2021, 44(8): 688-693. doi: 10.3969/j.issn.1006-2157.2021.08.003FU X, XIAO C, REN YF, et al. TCM tumorigenicity in the perspective of holism[J]. J Beijing Univ Tradit Chin Med, 2021, 44(8): 688-693. doi: 10.3969/j.issn.1006-2157.2021.08.003 [2] 田昊, 龚红卫, 李成银, 等. 基于"扶正祛邪"理论探讨消化系统肿瘤的免疫治疗[J]. 中医学, 2022, 11(1): 21-25.TIAN H, GONG HW, LI CY, et al. Discussion on the immunotherapy of digestive system tumors based on the theory of "Strengthening Healthy Qi to Eliminate Pathogens"[J]. Tradit Chin Med, 2022, 11(1): 21-25. [3] 游捷. 中医肿瘤病机、治疗与疗效评定的探讨[J]. 中国中西医结合杂志, 2018, 38(2): 158-160. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201802007.htmYOU J. Discussion on pathogenesis, treatment and effect evaluation of tumor based on traditional Chinese medicine[J]. Chin J Integr Tradit West Med, 2018, 38(2): 158-160. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201802007.htm [4] 程海波, 王俊壹, 李柳. 癌毒病机分类及其在肿瘤临床治疗中的应用[J]. 中医杂志, 2019, 60(2): 119-122. doi: 10.3969/j.issn.0411-8421.2019.02.023CHENG HB, WANG JY, LI L. Classification of pathogenesis of cancer toxin and application in the clinical treatment of cancer[J]. J Tradit Chin Med, 2019, 60(2): 119-122. doi: 10.3969/j.issn.0411-8421.2019.02.023 [5] 高卓维, 韩钦芮, 符秀琼, 等. 肿瘤微环境刚性的病机探讨[J]. 中国中医基础医学杂志, 2020, 26(12): 1808-1810. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC202012020.htmGAO ZW, HAN QR, FU XQ, et al. Pathogenesis of tumor microenvironment stiffness[J]. J Basic Chin Med, 2020, 26(12): 1808-1810. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC202012020.htm [6] 滕文静, 李洪林, 李雁. 基于扶正抗癌理论的温阳散寒中药抗肺癌作用初探[J]. 中华中医药杂志, 2018, 33(5): 2023-2028. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201805075.htmTENG WJ, LI HL, LI Y. Preliminary study on the effects of Chinese herbal medicine for warming Yang and dispelling coldness on lung cancer[J]. China J Tradit Chin Med Pharm, 2018, 33(5): 2023-2028. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201805075.htm [7] 高治理, 郝宇, 贺娟. 从"阳虚阴盛"论肿瘤病机[J]. 环球中医药, 2019, 12(3): 437-439. doi: 10.3969/j.issn.1674-1749.2019.03.033GAO ZL, HAO Y, HE J. Discussion on tumor pathology based on "overabundant yin and deficiency yang"[J]. Glob Tradit Chin Med, 2019, 12(3): 437-439. doi: 10.3969/j.issn.1674-1749.2019.03.033 [8] 内经[M]. 北京: 人民卫生出版社, 2000.The Inner Classic[M]. Beijing: The people's medical publishing house, 2000. [9] 张介宾. 景岳全书[M]. 北京: 人民卫生出版社, 1991: 510.ZHANG JB. The Complete Works of[Zhang] Jing-Yue[M]. Beijing: The people's medical publishing house, 1991: 510. [10] 吴昊, 魏吉红, 郑瑾, 等. 论阳虚与肿瘤形成的关系[J]. 中华中医药杂志, 2017, 32(3): 969-971. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201703022.htmWU H, WEI JH, ZHENG J, et al. Discussion on relationship between Yang deficiency and tumor formation[J]. China J Tradit Chin Med Pharm, 2017, 32(3): 969-971. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201703022.htm [11] 郭威堂, 汪鸣, 韩琦, 等. 论阳虚体质与肿瘤的发病关系[J]. 中医药信息, 2016, 33(6): 17-19. doi: 10.3969/j.issn.1002-2406.2016.06.007GUO WT, WANG M, HAN Q, et al. The relationship between Yang deficiency constitution and tumor[J]. Inf Tradit Chin Med, 2016, 33(6): 17-19. doi: 10.3969/j.issn.1002-2406.2016.06.007 [12] 郑里翔, 王萍, 邓佳卉, 等. 阴虚、阳虚体质血清对肺癌细胞NF-κB、P16基因表达的影响[J]. 中华中医药杂志, 2013, 28(9): 2563-2566. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201309021.htmZHENG LX, WANG P, DENG JH, et al. Effects of Yin-Yang deficiency constitutional types serum on NF-κB and P16 expression in lung cancer cell[J]. China J Tradit Chin Med Pharm, 2013, 28(9): 2563-2566. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201309021.htm [13] 殷东风, 郭羽永, 邢玉庆, 等. 中国肿瘤患者韩医四象人体质的临床研究[J]. 亚太传统医药, 2012, 8(1): 5-8. doi: 10.3969/j.issn.1673-2197.2012.01.003YIN DF, GUO YY, XING YQ, et al. Clinical character of Chinese cancer patients base on the four images theory of Korean medicine[J]. Asia Pac Tradit Med, 2012, 8(1): 5-8. doi: 10.3969/j.issn.1673-2197.2012.01.003 [14] 周微红. 胃癌患者中医体质与临床证型的调查研究[D]. 杭州: 浙江中医药大学, 2013.ZHOU WH. Investigation and research on physical type of TCM and syndrome differentiation of TCM with regard to gastric cancer[D]. Hangzhou: Zhejiang Chinese Medical University, 2013. [15] 赵苗苗, 曾宝珠, 杜敏, 等. 大肠癌与中医体质及相关危险因素Logistic回归分析[J]. 中国中西医结合杂志, 2019, 39(1): 23-27.ZHAO MM, ZENG BZ, DU M, et al. Logistic regression analysis between colorectal cancer and traditional Chinese medicine constitutions and related risk factors[J]. Chin J Integr Tradit West Med, 2019, 39(1): 23-27. [16] 杨必安, 遆保忠. 四种中医体质偏颇与肿瘤筛查及其康复的关联性研究[J]. 中医杂志, 2010, 51(S2): 169. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ2010S2166.htmYANG BA, TI BZ. Different tumor screening and treatment results between people with different four kinds of traditional Chinese medicine constitution[J]. J Tradit Chin Med, 2010, 51(S2): 169. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ2010S2166.htm [17] 龚胜男, 黎军宏, 梁新梅, 等. 温阳复方联合化疗治疗非小细胞肺癌的Meta分析[J]. 吉林中医药, 2019, 39(10): 1304-1309. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJL201910014.htmGONG SN, LI JH, LIANG XM, et al. Meta-analysis of Wenyang prescription combined with chemotherapy in the treatment of non-small cell lung cancer[J]. Jilin J Chin Med, 2019, 39(10): 1304-1309. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJL201910014.htm [18] 张学娅, 饶宇东, 郭春霞, 等. 《内经》"阳化气, 阴成形"含义探讨[J]. 辽宁中医杂志, 2020, 47(4): 80-82. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY202004027.htmZHANG XY, RAO YD, GUO CX, et al. Discussion on theory of "Yang transforming qi and Yin transforming shape" in Neijing[J]. Liaoning J Tradit Chin Med, 2020, 47(4): 80-82. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY202004027.htm [19] 许博文, 李杰, 高瑞珂, 等. 基于"阳化气, 阴成形"理论探讨肿瘤的中医辨治[J]. 中医杂志, 2020, 61(4): 315-318. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202004011.htmXU BW, LI J, GAO RK, et al. On the treatment of tumor in traditional Chinese medicine based on the theory of "Yang transforming qi, Yin shaping up body"[J]. J Tradit Chin Med, 2020, 61(4): 315-318. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202004011.htm [20] NAKANUMA Y, TERADA T, UEDA K, et al. Adenomatous hyperplasia of the liver as a precancerous lesion[J]. Liver, 1993, 13(1): 1-9. [21] BERRETTA R, GIZZO S, DALL'ASTA A, et al. Risk of preterm delivery associated with prior treatment of cervical precancerous lesion according to the depth of the cone[J]. Dis Markers, 2013, 35(6): 721-726. [22] PIMENTEL-NUNES P, DINIS-RIBEIRO M, SOARES JB, et al. A multicenter validation of an endoscopic classification with narrow band imaging for gastric precancerous and cancerous lesions[J]. Endoscopy, 2012, 44(3): 236-246. doi: 10.1055/s-0031-1291537 [23] 赵元辰, 刘世刚. 肺部结节的中西医诊治探讨[J]. 中国医药导报, 2020, 17(5): 192-196. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202005049.htmZHAO YC, LIU SG. Discussion on diagnosis and treatment of pulmonary nodules in Chinese and western medicine[J]. China Med Her, 2020, 17(5): 192-196. https://www.cnki.com.cn/Article/CJFDTOTAL-YYCY202005049.htm [24] 陈昫, 胡玲, 龚琳, 等. 消化道息肉发生与中医体质状态和证候关联的思考[J]. 中华中医药杂志, 2015, 30(7): 2425-2427. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201507056.htmCHEN X, HU L, GONG L, et al. Thinking on the relationship between digestive tract polyps and TCM constitution and symptom[J]. China J Tradit Chin Med Pharm, 2015, 30(7): 2425-2427. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201507056.htm [25] DASKIVICH TJ, FAN KH, KOYAMA T, et al. Effect of age, tumor risk, and comorbidity on competing risks for survival in a US population-based cohort of men with prostate cancer[J]. Ann Intern Med, 2013, 158(10): 709-717. doi: 10.7326/0003-4819-158-10-201305210-00005 [26] 沙宇婷, 王雪威, 王宝华. 中国南方胃癌危险因素病例-对照研究Meta分析[J]. 中华肿瘤防治杂志, 2020, 27(15): 1269-1276. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL202015017.htmSHA YT, WANG XW, WANG BH. Meta-analysis of risk factors for gastric cancer in southern China based on case-control study covering 2005-present[J]. Chin J Cancer Prev Treat, 2020, 27(15): 1269-1276. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL202015017.htm [27] 尤怡. 金匮要略心典[M]. 北京: 人民军医出版社, 2009: 101.YOU Y. Annotation on Essentials from the Golden Cabinet[M]. Beijing: The people's military' medical press, 2009: 101. [28] 杜金行. 伏阳辨析及其临床意义[J]. 中华中医药杂志, 2008, 23(11): 964-966. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY200811009.htmDU JH. Clinical differentiation and analysis of insidious Yang[J]. China J Tradit Chin Med Pharm, 2008, 23(11): 964-966. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY200811009.htm [29] 鲁玉, 赵远红. 以"痞坚之处, 必有伏阳"探讨癌性发热病机[J]. 国医论坛, 2016, 31(4): 54-55. https://www.cnki.com.cn/Article/CJFDTOTAL-GYLT201604036.htmLU Y, ZHAO YH. Discussion of pathogenesis of cancer fever based on tumor with Lurk-yang[J]. Forum Tradit Chin Med, 2016, 31(4): 54-55. https://www.cnki.com.cn/Article/CJFDTOTAL-GYLT201604036.htm [30] VIALLARD C, LARRIVEE B. Tumor angiogenesis and vascular normalization: Alternative therapeutic targets[J]. Angiogenesis, 2017, 20(4): 409-426. doi: 10.1007/s10456-017-9562-9 [31] 张亚龙, 房念珍, 尤嘉琮, 等. 肿瘤细胞代谢与肿瘤转移相互关系的研究进展[J]. 中国肺癌杂志, 2014, 17(11): 812-818. doi: 10.3779/j.issn.1009-3419.2014.11.07ZHANG YL, FANG NZ, YOU JC, et al. Advances in the relationship between tumor cell metabolism and tumor metastasis[J]. Chin J Lung Cancer, 2014, 17(11): 812-818. doi: 10.3779/j.issn.1009-3419.2014.11.07 [32] 郭教礼, 唐尚有, 贾孟辉. 类经评注: 上[M]. 西安: 陕西科学技术出版社, 1996: 16.GUO JL, TANG SY, JIA MH. Commentary on "Classified classic": Volume Ⅰ[M]. Xi'an: Shaanxi scientific and technical press, 1996: 16. [33] 苏化, 李世杰, 熊绍权, 等. 基于"伏阳-病络"论肿瘤复发与转移的病机[J]. 江苏中医药, 2018, 50(9): 11-12. doi: 10.3969/j.issn.1672-397X.2018.09.004SU H, LI SJ, XIONG SQ, et al. The pathogenesis of tumor recurrence and metastasis based on the theory of "Fuyang-disease into collaterals"[J]. Jiangsu J Tradit Chin Med, 2018, 50(9): 11-12. doi: 10.3969/j.issn.1672-397X.2018.09.004 [34] 苏化, 李世杰, 熊绍权, 等. 从"伏阳"论治化疗后消化道反应[J]. 中国中医基础医学杂志, 2019, 25(5): 592-593. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC201905011.htmSU H, LI SJ, XIONG SQ, et al. Treatment of digestive tract reaction syndrome after chemotherapy from "Fuyang"[J]. Chin J Basic Med Tradit Chin Med, 2019, 25(5): 592-593. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC201905011.htm [35] CHEN ZY, GUO PY, XIE XZ, et al. The role of tumour microenvironment: A new vision for cholangiocarcinoma[J]. J Cell Mol Med, 2019, 23(1): 59-69. doi: 10.1111/jcmm.13953 [36] WANG WX, WU J, JI M, et al. Exogenous interleukin-33 promotes hepatocellular carcinoma growth by remodelling the tumour microenvironment[J]. J Transl Med, 2020, 18(1): 477. doi: 10.1186/s12967-020-02661-w [37] MARU Y. The lung metastatic niche[J]. J Mol Med, 2015, 93(11): 1185-1192. doi: 10.1007/s00109-015-1355-2 [38] AGUADO BA, BUSHNELL GG, RAO SS, et al. Engineering the pre-metastatic niche[J]. Nat Biomed Eng, 2017, 1: 77. doi: 10.1038/s41551-017-0077 [39] 刘杨, 巩阳, 林一帆, 等. 温阳散结汤预防结肠息肉术后复发的临床研究[J]. 中国中西医结合消化杂志, 2016, 24(7): 509-511. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXPW201607006.htmLIU Y, GONG Y, LIN YF, et al. Clinical study on the prevention of postoperative recurrence of colon polyps by Wenyang Sanjie Decoction[J]. Chin J Integr Tradit West Med Dig, 2016, 24(7): 509-511. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXPW201607006.htm [40] 倪炎炎, 倪青. 温阳健脾法治疗甲状腺结节并子宫肌瘤和乳腺增生1例[J]. 北京中医药, 2017, 36(6): 556-557. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO201706030.htmNI YY, NI Q. A case report of thyroid nodules complicated with uterine fibroids and mastitis treated by Wenyang Jianpi method[J]. Beijing J Tradit Chin Med, 2017, 36(6): 556-557. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO201706030.htm [41] 刘晓菲, 殷玉琨, 王蕾, 等. 阳和化岩汤对大鼠乳腺癌癌前病变的抑制作用研究[J]. 中华中医药学刊, 2014, 32(2): 284-287. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201402020.htmLIU XF, YIN YK, WANG L, et al. Study about Yanghe Huayan Decoction inhibiting breast precancerous lesion of rats[J]. Chin Arch Tradit Chin Med, 2014, 32(2): 284-287. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201402020.htm [42] 王景良, 汤继军. 从"阳虚阴结"论治恶性肿瘤[J]. 中医杂志, 2016, 57(10): 887-889. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201610019.htmWANG JL, TANG JJ. Treatment of malignant tumor from "Yang deficiency and Yin knot"[J]. J Tradit Chin Med, 2016, 57(10): 887-889. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201610019.htm [43] 郭佼, 孙旭, 念家云, 等. 性味归经及引经理论在肿瘤治疗中的应用[J]. 环球中医药, 2017, 10(1): 106-108. doi: 10.3969/j.issn.1674-1749.2017.01.036GUO J, SUN X, NIAN JY, et al. Application of the theory of drug properties and channel tropism in tumor treatment[J]. Glob Tradit Chin Med, 2017, 10(1): 106-108. doi: 10.3969/j.issn.1674-1749.2017.01.036 [44] 王俊壹, 程海波. 清热解毒法与以毒攻毒法在肿瘤治疗中的应用[J]. 中华中医药杂志, 2018, 33(8): 3417-3419. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201808051.htmWANG JY, CHENG HB. Application of clearing heat and removing toxicity therapy and counteracting toxin with toxin therapy in tumor treatment[J]. China J Tradit Chin Med Pharm, 2018, 33(8): 3417-3419. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201808051.htm [45] 由凤鸣, 郑川, 于海艳, 等. 中医归经理论、引经药与肿瘤靶向药物治疗[J]. 时珍国医国药, 2015, 26(5): 1185-1186. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY201505061.htmYOU FM, ZHENG C, YU HY, et al. The theory of channel tropism in TCM and tumor target drug therapy[J]. Lishizhen Med Mater Med Res, 2015, 26(5): 1185-1186. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY201505061.htm [46] 程海波, 周仲瑛. 癌毒病机科学内涵的现代诠释[J]. 南京中医药大学学报, 2021, 36(5): 637-641. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY202105001.htmCHENG HB, ZHOU ZY. Modern interpretation of the scientific connotation of the pathogenesis of cancerous toxin[J]. J Nanjing Univ Tradit Chin Med, 2021, 36(5): 637-641. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY202105001.htm [47] 孙睿博, 韩钦芮, 徐萌, 等. 肿瘤转移前龛环境的正虚痰瘀病机探讨[J]. 中华中医药杂志, 2021, 36(6): 3529-3532. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202106111.htmSUN RB, HAN QR, XU M, et al. Discussion on pathogenesis of deficiency of healthy-qi and stagnation of phlegm and blood in tumor pre-metastatic niche[J]. China J Tradit Chin Med Pharm, 2021, 36(6): 3529-3532. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202106111.htm -
下载:
点击查看大图
图(1)
计量
- 文章访问数: 751
- HTML全文浏览量: 72
- PDF下载量: 126
- 被引次数: 0
